Solvay Pharmaceuticals clinical trials

Acquired by Abbott, Feb 15, 2010 · source ↗

The registry lists 86 studies whose lead sponsor is Solvay Pharmaceuticals. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 27, 2015.

Studies

Recruiting first, then most recently updated. Showing 50 of 86. List all 86 → · All Abbott studies →

• SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor FluctuationsCompletedNCT00406588Phase 3

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's TypeTerminatedNCT00160147Phase 3

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 DiabetesCompletedNCT00141492Phase 2

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Effect of Fenofibrate on Kidney Function: a Six-week Randomized Cross-over Trial in Healthy PeopleCompletedNCT00543647Phase 1

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female SubjectsCompletedNCT00126074Phase 3

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female SubjectsCompletedNCT00126022Phase 3

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine HeadacheCompletedNCT00123201Phase 2

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Bifeprunox in the Treatment of SchizophreniaCompletedNCT00193713Phase 3

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar DisorderCompletedNCT00139919Phase 2

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal WomenCompletedNCT00141570Phase 2

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Twice Daily Titration Study of Bifeprunox in Subjects With SchizophreniaCompletedNCT00139906Phase 2

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• To Evaluate the Impact of Treatment Interruption on Re-initiation of BifeprunoxCompletedNCT00141479Phase 2

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With HypogonadismCompletedNCT00193661Phase 2

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• PK Effects of Bifeprunox & Valproate in Bipolar ICompletedNCT00141505Phase 2

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male SubjectsCompletedNCT00126061Phase 3

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Patient-reported Outcomes in the Treatment of SchizophreniaCompletedNCT00230828Phase 3

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and PancreatectomyCompletedNCT00414908Phase 3

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency Due to Cystic FibrosisCompletedNCT00775528Phase 3

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Safety and Efficacy Study to Evaluate the Effect of SLV320 on Renal Function in Patients With Worsening Heart FailureTerminatedNCT00744341Phase 2

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Study to Investigate ADME of 14C Labeled SLV334 After an i.v. InfusionCompletedNCT01044524Phase 1

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.CompletedNCT00407095Phase 3

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory ConversionCompletedNCT00160199Phase 4

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic FibrosisCompletedNCT00510484Phase 3

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency (PEI) Due to Cystic Fibrosis (CF)CompletedNCT00690820Phase 3

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• First in Man Study With SLV341TerminatedNCT00887445Phase 1

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Effects of Fenofibrate on Gene Expression in Healthy VolunteersCompletedNCT01109758Phase 1

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted after Solvay Pharmaceuticals became part of Abbott

• Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFOCompletedNCT00362323Phase 3

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• A Methodological Study To Evaluate The Effects of Single Oral Doses Of Pioglitazone 45 mg And Rosiglitazone 8 mg On Sodium Balance In Healthy Male VolunteersCompletedNCT01088594Phase 1

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted after Solvay Pharmaceuticals became part of Abbott

• Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and AdolescentsTerminatedNCT00352768Phase 4

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and AdolescentsCompletedNCT00353028Phase 4

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Annual Study to Investigate Inactivated Virosomal Influenza Vaccine for the 2006/2007 Influenza Season in Europe.WithdrawnNCT00345462Phase 3

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Safety and Tolerability of the First IV Dosing of SLV338 in Healthy VolunteersCompletedNCT00885989Phase 1

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Study of Serum Testosterone Levels in Non-dosed Females After Secondary ExposureCompletedNCT00998933Phase 1

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Interaction Study SLV337/SimvastatinCompletedNCT00924430Phase 1

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chronic PancreatitisTerminatedNCT00630279Phase 2

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Effect of Fenofibrate on Sleep Apnea SyndromeTerminatedNCT00816829Phase 2

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Comparison of the Combination of Fenofibrate and Simvastatin Versus AtorvastatinCompletedNCT00362934Phase 3

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Comparison of the Combination of Fenofibrate and Simvastatin Versus PravastatinCompletedNCT00362206Phase 3

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin MonotherapyCompletedNCT00349375Phase 3

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin MonotherapyCompletedNCT00352183Phase 3

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Study to Compare the Effect of Hormone Replacement Therapy (HRT) on Breast and Cardiovascular Metabolic Markers in Postmenopausal WomenCompletedNCT00145522Phase 4

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Effect of Omacor on Triglycerides in HIV Infected SubjectsTerminatedNCT00598910Phase 4

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD PatientsCompletedNCT00335374Phase 3

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II DiabetesCompletedNCT00160160Not applicable

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With HypertensionCompletedNCT00160212Phase 2

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Annual Study to Investigate Inactivated Subunit Influenza Vaccine for the 2006/2007 Influenza Season in Europe.CompletedNCT00346723Phase 3

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart FailureCompletedNCT00160134Phase 2

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Annual Study to Investigate Influenza Vaccine Due to New Virus Strains for the 2007/2008 Influenza Season in EuropeCompletedNCT00479921Phase 3

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Study to Investigate if Adding Lactulose to Vitamin D and Calcium Has an Effect on the Preservation of Bone in Postmenopausal WomenCompletedNCT00160264Phase 4

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott

• Efficacy and Safety of Moxonidine in Indian PatientsCompletedNCT00160277Phase 3

  Sponsor listed in the registry: Solvay Pharmaceuticals · First submitted before Solvay Pharmaceuticals became part of Abbott